CalciMedica (CALC) Current Assets (2019 - 2026)
CalciMedica's (CALC) quarterly Current Assets came in at $8.6 million in Q1 2026, down 66.08% YoY from $25.2 million in Q1 2025, and down 36.77% on a QoQ basis from $13.5 million in Q4 2025.
CalciMedica (CALC) Current Assets (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Current Assets data on file, last reported at $8.6 million in Q1 2026.
- Quarterly Current Assets fell 66.08% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (down 66.08% YoY) and the FY2025 annual result came in at $13.5 million, down 31.2% from the prior year.
- Current Assets fell to $8.6 million in Q1 2026, from $13.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $58.2 million in Q1 2022 to a low of $1.7 million in Q4 2022.
- A 5-year average of $23.6 million and a median of $19.7 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 97.42% — and 2023, when it soared 570.81%.
- Tracing CALC's Current Assets over 5 years: stood at $1.7 million in 2022, then soared by 570.81% to $11.6 million in 2023, then soared by 69.45% to $19.7 million in 2024, then sank by 31.2% to $13.5 million in 2025, then tumbled by 36.77% to $8.6 million in 2026.
- The last three Current Assets figures came in at $8.6 million (Q1 2026), $13.5 million (Q4 2025), and $14.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | CalciMedica | 9.97 Mn | -8.65 Mn | - | 19.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.46 Mn |
| Mar 31, 2026 | 8.56 Mn |
| Dec 31, 2025 | 13.53 Mn |
| Sep 30, 2025 | 14.85 Mn |
| Jun 30, 2025 | 18.96 Mn |
| Mar 31, 2025 | 25.22 Mn |
| Dec 31, 2024 | 19.67 Mn |
| Sep 30, 2024 | 15.69 Mn |
| Jun 30, 2024 | 20.44 Mn |
| Mar 31, 2024 | 26.60 Mn |
| Dec 31, 2023 | 11.61 Mn |
| Sep 30, 2023 | 15.27 Mn |
| Jun 30, 2023 | 20.05 Mn |
| Mar 31, 2023 | 34.50 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 45.07 Mn |
| Jun 30, 2022 | 51.73 Mn |
| Mar 31, 2022 | 58.22 Mn |
| Dec 31, 2021 | 67.08 Mn |
| Sep 30, 2021 | 74.50 Mn |